Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-10Clinical Trial Results: Study to Evaluate the Effect of Bepirovirsen on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers [Phase 1]
Phase 1 trial evaluating the effect of Bepirovirsen on cardiac conduction in healthy volunteers; results completed and posted.
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Results: Liver Fibrosis in Zambian HIV-HBV Co-infected Patients
Clinical trial results in Zambian HIV-HBV co-infected patients evaluated liver fibrosis outcomes; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2026-06-16Clinical Trial Results: Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection [Phase 1, Phase 2]
Phase 1/2 study of GSK3965193 in healthy participants and individuals with chronic Hepatitis B was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2026-04-29Clinical Trial Results: Open-Label Study of AB-729, Nucleos(t)Ide Analogue and Pegylated Interferon Alfa-2a in Subjects With Chronic Hepatitis B Infection [Phase 2]
Phase 2 open-label study results of AB-729 (nucleos(t)ide analogue) combined with pegylated interferon alfa-2a in chronic hepatitis B; study…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b Cirrhosis [Phase 1]
A Phase 1 clinical trial is evaluating hUC mesenchymal stem cells (19#iSCLife®-LC) for decompensated hepatitis B cirrhosis. The study is spo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection [Phase 2]
Vir Biotechnology reports that the Phase 2 study of VIR-2218, VIR-3434, and PEG-IFNα for chronic hepatitis B infection has been completed. T…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Social-environmental, Psychosocial, Behavioral, Clinical and Biological Drivers of Disparities in Liver Disease Progression Among Korean American With Chronic Hepatitis B Infection
This completed clinical trial examines social, environmental, psychosocial, behavioral, clinical, and biological factors that drive disparit…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: A Long-term Observational Study in Participants Who Have Received PBGENE-HBV
This update describes a long-term observational study following participants who have received PBGENE-HBV to assess outcomes in chronic hepa…
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Study of Oral TLR8 Agonist Selgantolimod on HBsAg in Participants With Both Chronic Hepatitis B and HIV [Phase 2]
Phase 2 trial of the oral TLR8 agonist Selgantolimod (GS-9688) on HBsAg in participants with chronic hepatitis B and HIV has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease
This completed study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) evaluated the response to COV…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Study of VIR-2218 With or Without Pegylated Interferon Alpha-2a for Treatment of Chronic Hepatitis B Virus Infection [Phase 2]
Phase 2 study evaluating VIR-2218 with or without pegylated interferon alfa-2a for chronic hepatitis B has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: HBV Vaccination of Healthy Volunteers to Evaluate the Composition of Germinal Centers [Phase 4]
A Phase 4 clinical trial evaluating hepatitis B vaccination in healthy volunteers to study germinal center composition was terminated.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Safety, Tolerability, PK & PD of AB-101 Following Oral Administration in Healthy and CHB Subjects. [Phase 1]
Phase 1 study evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of orally administered AB-101 in healthy volunteers and…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Trial Comparing Two Strategies of Vaccination Against Hepatitis B in HIV-infected Patients Non Responding to Primary Immunization (B-BOOST) [Phase 3]
A Phase 3 trial comparing two vaccination strategies against hepatitis B in HIV-infected adults who did not respond to initial immunization …
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: A Clinical Study of HH-006 in Untreated Chronic Hepatitis B Virus Infected Patients [Phase 1]
This document reports the completion of a Phase 1 clinical trial evaluating HH-006 in untreated chronic hepatitis B virus infection.
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected Patients [Phase 3]
Phase 3 trial evaluating three hepatitis B vaccination strategies in HIV-infected patients has completed. The study compared different HBV v…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: ANRS HB 05 Multicenter Study Evaluating Efficacy and Safety of Clevudine Monotherapy Versus Tenofovir Monotherapy Versus Combination Therapy of Clevudine and Tenofovir for 96 Weeks in HBeAg Negative Patients With Chronic Hepatitis B, naïve to Anti-VHB Therapy [Phase 3]
Phase 3 trial evaluating clevudine monotherapy, tenofovir monotherapy, and their combination in HBeAg-negative chronic hepatitis B was termi…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: A Phase I Clinical Study of AHB - 171 in Healthy Participants(HP) and Chronic Hepatitis B (CHB) Participants [Phase 1]
This Phase I trial evaluates AHB-171 in healthy participants and patients with chronic hepatitis B; the study is currently not yet recruitin…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Efficacy and Tolerance of Naked DNA Vaccine in Patients With Chronic B Hepatitis [Phase 1, Phase 2]
A Phase 1/2 clinical trial assessed the efficacy and tolerability of a naked DNA vaccine in patients with chronic hepatitis B; the study sta…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic Fibrosis and Liver Cirrhosis [Phase 3]
A Phase 3 clinical trial evaluating the safety of Hydronidone capsules in patients with hepatic fibrosis and liver cirrhosis due to chronic …
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: [¹⁴C] Hydronidone Mass Balance Study [Phase 1]
Phase 1 mass balance pharmacokinetic study of [14C] Hydronidone in patients with chronic hepatitis B-related liver fibrosis; the trial is no…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Adaptability of an Undetectable = Untransmissible Model for HBV
This clinical trial update concerns an HBV study testing an undetectable = untransmissible model; the trial is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: Optimizing HBV Care Cascade Among Foreign-Born in the United States (FOCUS-HBV Study)
The FOCUS-HBV study, sponsored by NIDDK, has completed its trial evaluating strategies to optimize the hepatitis B care cascade among foreig…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Single Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Participants With Renal Impairment and in Healthy Participants With Normal Renal Function [Phase 1]
Phase 1 single-dose pharmacokinetics, safety and tolerability study of Pevifoscorvir Sodium (ALG-000184) in participants with renal impairme…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Chronic Hepatitis b Patients Switch to tAf After Discontinuation of Nucleoside Analogue [Phase 4]
Phase 4 trial update reports chronic hepatitis B patients switching to tenofovir alafenamide after stopping prior nucleoside analogue therap…